Intensive care unit drug utilization in a teaching hospital in Nepal

Kathmandu University Medical Journal

Volumn 3 no. 2, Issue 10, 2005, Pages 130-137

  Shankar, P R ^a   Partha, P ^a   Dubey, A K ^a   Mishra, P ^a   Deshpande, V Y ^a  

^a MANIPAL COLLEGE OF MEDICAL SCIENCES   (Nepal)

Author keywords

Antibiotic sensitivity patterns; Defined daily dose; Drug utilization; Intensive care unit

Indexed keywords

ANTIINFECTIVE AGENT;

ARTICLE; DRUG RESISTANCE; DRUG USE; FEMALE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MALE; MICROBIOLOGICAL EXAMINATION; MIDDLE AGED; MORTALITY; NEPAL; ORGANIZATION AND MANAGEMENT; RETROSPECTIVE STUDY; TEACHING HOSPITAL;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE; DRUG UTILIZATION REVIEW; FEMALE; HOSPITAL MORTALITY; HOSPITALS, TEACHING; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NEPAL; RETROSPECTIVE STUDIES;

EID: 39049189648     PISSN: 18122027     EISSN: 18122078     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. WHO. The selection of essential drugs. WHO Technical report 1977;615: 36.
2. Kollef MH, Fraser VJ. Antibiotic resistance in the intensive care unit setting. Ann Intern Med 2001;134: 298-314.
3. Dieckhaus KD, Cooper BW. Infection control concepts in critical care. Crit Care Clin 1998;14: 55-70.
4. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment. Oslo: WHO Collaborating Centre for Drug Statistics Methodology; 2002.
5. WHO Collaborating Centre for Drug Statistics Methodology. ATC index with DDDs. Oslo: WHO Collaborating Centre for Drug Statistics Methodology; 2002.
6. Shankar PR, Partha P, Shenoy N, Brahmadathan KN. Investigation of antimicrobial use pattern in the intensive treatment unit of a teaching hospital in western Nepal. Am J Infect Control 2003;31: 410-414.
7. Berenholtz SM, Dorman T, Ngo K, Pronovost PJ. Qualitative review of intensive care unit quality indicators. J Crit Care 2002;17: 1-12.
8. Smythe MA, Melendy S, Jahns B, Dmuchowski C. An exploratory analysis of medication utilization in a medical intensive care unit. Crit Care Med 1993;21: 1319-1323.
9. Boucher BA, Kuhl DA, Coffey BC, Fabian TC. Drug use in a trauma intensive-care unit. Am J Hosp Pharm 1990;47: 805-810.
10. Bonmarchand G, Czernichow P, Chretein P, Massari P, Lecomte F, Hantute N et al. Drugs used in a medical intensive care unit. Ann Fr Anesth Reanim 1986;5: 497-501.
11. Stratton CW 4th, Ratner H, Johnston PE, Schaffner W. Focused microbiological surveillance by specific hospital unit: practical application and clinical utility. Clin Ther 1993;15 Suppl A: 12-20.
12. Meyer E, Jonas D, Schwab F, Rueden H, Gastmeier P, Daschner FD. Design of a surveillance system of antibiotic use and bacterial resistance in German intensive care units (SARI). Infection 2003;31: 208-215.
13. Walther SM, Erlandsson M, Burman LG, Cars O, Gill H, Hoffman M et al. Antibiotic prescription practices, consumption and bacterial resistance in a cross section of Swedish intensive care units. Acta Anaesthesiol Scand 2002;46: 1075-1081.
14. Bergmans DC, Bonten MJ, Gaillard CA, van Tiel FH, van der Geest S, de Leeuw PW, et al. Indications for antibiotic use in ICU patients: a one-year prospective surveillance. J Antimicrob Chemother 1997;39: 527-535.
15. Borderon JC, Laugier J, Ramponi N Saliba E, Gold F, Blond MH et al. Surveillance of antibiotic therapy in a pediatric intensive care unit. Ann Pediatr Paris 1992;39:27-36.
16. Kollef M, Niederman M. Antimicrobial resistance in the ICU: The time for action is now. Crit Care Med 2001; 29 (4 Suppl):N63.
17. Kollef MH. Is there a role for antibiotic cycling in the intensive care unit? Crit Care Med 2001;29(4 Suppl):N135-N142.
18. Weber RJ, Kane SL, Oriolo VA, Saul M, Skledar SJ, Dasta JF. Impact of intensive care unit (ICU) drug use on hospital costs: a descriptive analysis, with recommendations for optimizing ICU pharmacotherapy. Crit Care Med 2003;31 (1 Suppl): S17-S24.